Please Wait
Applying Filters...
menu
    • menu
    Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Currax

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2CURRAX

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    CURRAX

    DOXEPIN HYDROCHLORIDE

    arrow
    IFT FIRST
    Not Confirmed

    CURRAX

    U.S.A
    arrow
    IFT FIRST
    Not Confirmed

    Patent Expiration Date : 2027-05-18

    DOXEPIN HYDROCHLORIDE

    US Patent Number : 10238620

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 22036

    Patent Use Code : U-620

    Delist Requested :

    Patent Use Description : TREATMENT OF INSOMNIA

    Patent Expiration Date : 2027-05-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    CURRAX

    DOXEPIN HYDROCHLORIDE

    arrow
    IFT FIRST
    Not Confirmed

    CURRAX

    U.S.A
    arrow
    IFT FIRST
    Not Confirmed

    Patent Expiration Date : 2027-05-18

    DOXEPIN HYDROCHLORIDE

    US Patent Number : 10238620

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 22036

    Patent Use Code : U-620

    Delist Requested :

    Patent Use Description : TREATMENT OF INSOMNIA

    Patent Expiration Date : 2027-05-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF